Aurinia Pharmaceuticals (AUPH) Change in Account Payables (2024 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Change in Account Payables of -$652000.0 for Q1 2026, down 159.33% on a QoQ basis from $1.1 million in Q4 2025, and up 33.06% year-over-year from -$490006.2 in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Change in Account Payables (2024 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Change in Account Payables history runs 3 years deep, the most recent figure standing at -$652000.0 for Q1 2026.
- Quarterly Change in Account Payables rose 33.06% year-over-year to -$652000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 6.37% YoY) and the FY2025 annual result came in at -$1.9 million, down 317.91% from the prior year.
- Change in Account Payables was -$652000.0 for Q1 2026 at Aurinia Pharmaceuticals, down from $1.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.7 million in Q2 2024 and bottomed at -$3.7 million in Q4 2024.
- A 3-year average of -$185111.1 and a median of -$652000.0 in 2026 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 129.78% in 2025, while the deepest fall reached 337.15% in 2025.
- Aurinia Pharmaceuticals' Change in Account Payables stood at -$3.7 million in 2024, then surged by 129.78% to $1.1 million in 2025, then sank by 159.33% to -$652000.0 in 2026.
- Business Quant data shows AUPH's Change in Account Payables at -$652000.0 in Q1 2026, $1.1 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | -652,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -652,000.00 |
| Mar 31, 2026 | -652,000.00 |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | -1.10 Mn |
| Sep 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | -901,000.00 |
| Jun 30, 2025 | -901,000.00 |
| Mar 31, 2025 | -974,000.00 |
| Mar 31, 2025 | -974,000.00 |
| Dec 31, 2024 | -3.69 Mn |
| Dec 31, 2024 | -3.69 Mn |
| Sep 30, 2024 | 463,000.00 |
| Sep 30, 2024 | 463,000.00 |
| Jun 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.74 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.35 Mn |